Samsø Biolab ApS

APSBankrupt

CVR 28151195Besservej 32, 8305 SamsøManufacture of perfumes and toilet preparations· NACE 2042Est. 2004 · 21 years old— employees

Overview

Samsø Biolab ApS is a Danish APS based in Samsø, operating in the Manufacture of perfumes and toilet preparations sector. Incorporated in 2004, the company reported revenue of DKK 16.9k in its latest annual filing.

Revenue 2022

16.9K DKK

−26% vs 2021

EBITDA margin

−42.3 %

+91% vs 2021

Net profit 2022

-7.5K DKK

+90% vs 2021

Key ratios

See full ratios →

-339.8 %

Very weak

Among the 10% lowest rated companies in the industry

20182022

0.2×

Very weak

Among the 10% lowest rated companies in the industry

20182022

-27.5 %

Very weak

Among the 20% lowest rated companies in the industry

20182022

EBITDA — year on year

DKK thousands

Key figures

Annual report 2022

Revenue	16.9K DKK	-26%
EBITDA	-7.1K DKK	+91%
Net profit	-7.5K DKK	+90%
Total assets	27.4K DKK	+24%
Equity	-93.1K DKK	-9%
Employees	—	—

Financial development

In its most recent annual report (2022), Samsø Biolab ApS reported revenue of DKK 16.9k, a decrease of 26% on the year before. The figures on this page draw on 5 annual filings covering 2018 to 2022. The bottom line showed a net loss of DKK 7.5k, and the EBITDA margin stood at -42.3%.

At the end of 2022, current assets covered short-term debt 0.2 times.

Financials

Revenue

DKK thousands

EBITDA

DKK thousands

Income statement

DKK thousands

Item	2022	2021	2020	2019	2018
Revenue	17	23	0	-40	-10
Staff expenses	-0	-0	-0	-0	-0
EBITDA	-7	-76	-22	-50	-10
Depreciation & amort.	-0	-0	-0	-0	-7
EBIT	-7	-76	-22	-50	-17
Net financials	-0	-1	-0	-0	0
Profit before tax	-8	-76	-22	-50	-17
Tax	-0	2	-5	-6	-0
Net profit	-8	-78	-17	-45	-17

Get a credit rating – not just the numbers

Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.

See the credit rating

Balance sheet

DKK thousands

Item	2022	2021	2020	2019	2018
Total assets	27	22	259	276	360
Equity	-93	-86	-7	10	54
Long-term debt	0	0	0	0	0
Short-term debt	120	108	266	266	306
Total debt	120	108	266	266	306

Financial ratios

5-year trend

EBITDA margin

-42.3 %

20182022

Equity ratio

-339.8 %

Very weak

Among the 10% lowest rated companies in the industry

20182022

Return on equity

—

20182022

Net profit margin

-44.6 %

Very weak

Among the 10% lowest rated companies in the industry

20182022

Asset turnover

0.62×

Weak

Among the 40% lowest rated companies in the industry

20182022

Debt / equity

—

20182022

Sector performance

20 of 28 ratios graded

28 financial ratios from the latest filing, each graded against companies in the same industry.

Profitability

Gross marginVery weak

Among the 10% lowest rated companies in the industry

The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.

Operating marginVery weak

Among the 10% lowest rated companies in the industry

EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.

Net profit marginVery weak

Among the 10% lowest rated companies in the industry

The profit for the year as a share of revenue — the company's ability to turn revenue into profit.

Return on assets (ROA)Very weak

Among the 20% lowest rated companies in the industry

Net profit as a percentage of total assets — the return generated on the capital employed.

Basic earning power (BEP)Very weak

Among the 20% lowest rated companies in the industry

EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.

Return on equity (ROE)Not rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Net profit as a percentage of equity — the return the owners earned on their invested capital this year.

Return on net assets (RONA)Not rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.

Capacity ratioNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.

Liquidity

Current ratioVery weak

Among the 10% lowest rated companies in the industry

Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.

Quick ratioVery weak

Among the 10% lowest rated companies in the industry

Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.

Cash ratioWeak

Among the 40% lowest rated companies in the industry

Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.

Cash conversion ratioWeak

Among the 30% lowest rated companies in the industry

Cash flow relative to profit — the ability to convert reported profits into accessible cash.

Current assets to equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.

Fixed assets to long-term capitalNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.

Debt & solvency

Solidity ratioVery weak

Among the 10% lowest rated companies in the industry

Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.

Debt ratioVery weak

Among the 10% lowest rated companies in the industry

Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.

Income to debtWeak

Among the 30% lowest rated companies in the industry

Profit relative to debt — the ability to create earnings while operating with debt.

EBITDA to debtWeak

Among the 30% lowest rated companies in the industry

EBITDA relative to debt — how much operating earnings are available to service the debt.

Interest coverageVery weak

Among the 20% lowest rated companies in the industry

The ability to pay the interest on the company's debt out of its earnings.

Interest rate on debtStrong

Among the 30% highest rated companies in the industry

Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.

Interest marginVery weak

Among the 20% lowest rated companies in the industry

The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.

Debt to equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.

Liabilities to equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.

Efficiency & development

Asset turnoverWeak

Among the 40% lowest rated companies in the industry

Revenue relative to total assets — the ability to generate revenue from the asset base.

Inventory turnoverStrong

Among the 30% highest rated companies in the industry

Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.

Equity to contributed capitalVery weak

Among the 20% lowest rated companies in the industry

Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.

One-year change in debtWeak

Among the 40% lowest rated companies in the industry

The size of this year's increase or decrease in the company's debt.

One-year change in equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The size of this year's increase or decrease in the company's equity.

Annual reports & filings

Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View PDF

People & ownership

Management

Actively employed in the business

Name	Role	Member since

Former (3)


JD Jette Dam Jonsson Management	Management	2004 – 2005
KA Karl Arne Jonsson Management	Management	2005 – 2023
AF Asger Fiig Audit	Audit	2004 – 2013

Board of directors

Non-executive oversight

No data on file.

Shareholders

Active legal owners

Shareholder	Type	Ownership	Votes	Registered
Jette Dam Jonsson	Individual	100%	100%	2004

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.

One in three Danish companies experiences fraud

Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.

See the fraud module

Related companies

Company hierarchy

No registered parent or subsidiaries

Board network connections

Board members of Samsø Biolab ApS also hold positions in 3 other companies.

Person	Role here	Other companies
Asger Fiig	Audit	2 companies
Jette Dam Jonsson	Management	1 company

Frequently asked questions

What is the CVR number of Samsø Biolab ApS?

Samsø Biolab ApS is registered with CVR / Virk under CVR 28151195.

What is the revenue of Samsø Biolab ApS?

Samsø Biolab ApS reported revenue of DKK 16.9k in 2022.

Where is Samsø Biolab ApS headquartered?

Samsø Biolab ApS's registered address is Besservej 32.